Startups channel feed

So­lid­i­fy­ing a new cor­po­rate struc­ture, IFM launch­es sec­ond unit fo­cused on cGAS-STING

7 years ago

Canaan leaps in­to UK biotech by co-lead­ing $14M Se­ries A for im­muno-on­col­o­gy up­start Grey Wolf

7 years ago
Financing

Rut­gers sci­en­tists form im­muno-on­col­o­gy biotech to de­vel­op pipeline of TAM in­hibitors

7 years ago

Arch joins Cel­gene, Chi­na in­vestors bankrolling a pi­o­neer­ing New York biotech start­up fo­cused on a new ap­proach to metas­ta­sis

7 years ago
Financing

Ke­to in a pill? Jim Mel­lon de­buts an­ti-ag­ing joint ven­ture with the Buck ded­i­cat­ed to in­duc­ing ke­to­sis

7 years ago

Medicxi bankrolls the launch of a pair of biotech twins fo­cused on orex­ins for nar­colep­sy and more

7 years ago
Financing

Po­laris’ Amir Nashat pulls to­geth­er a $60M launch round to back the birth of a new biotech build­ing a drug de­vel­op­ment plat­form from scratch

7 years ago
Financing

The next 5 years: High­er R&D pro­duc­tiv­i­ty is here to stay, emerg­ing biotechs and new tech will have a big im­pact. But what about pric­ing?

7 years ago
R&D
Pharma

Cam­bridge spin­out grabs $23M round to launch a new cam­paign to tack­le pro­tein mis­fold­ing

7 years ago
Financing

Com­pu­ta­tion­al sci­en­tists de­sign a new IL-2 can­cer drug and spin it out in­to a biotech start­up

7 years ago
Discovery

Bet­ting on al­losteric mu­ta­tions dri­ving can­cer, Black Di­a­mond rais­es $85M in fresh round

7 years ago
Financing

How to build a biotech uni­corn: Get the star team in place, at­tract deep-pock­et VCs, paint a big pic­ture and raise up to $1B

7 years ago
Financing

Juno founders set their sights on cre­at­ing an ‘epic’ new biotech with high-rolling in­vestors at their back

7 years ago
People
Financing

With ear­ly-stage stud­ies un­der­way, Con­nect Bio­phar­ma­ceu­ti­cals clos­es $55M round to ad­vance im­mune mod­u­la­tors

7 years ago
Financing
China

Why did Liz Bar­rett turn her back on a top job at No­var­tis in ex­change for the helm of a biotech you nev­er heard of?

7 years ago
People
Peer Review

The year of liv­ing large: A fledg­ling Re­lay Ther­a­peu­tics reaps a whop­ping $400M ven­ture round, with Soft­Bank point­ing the way to a wind­fall

7 years ago
Financing

Lit­tle Tetra is prep­ping a PhII Alzheimer’s study. In fact, they just got $40M to fund it

7 years ago

Tar­get­ing un­der­ly­ing cause of PAH, Cam­bridge spin­out Mor­phogen-IX rais­es about $23M in Se­ries B

7 years ago
Financing

En­tra­da launch­es to­day, tak­ing a $59M shot at some tough in­tra­cel­lu­lar tar­gets

7 years ago
Financing

Jonathan Lim is­n't ready to say much about his new start­up, but he does have $42M for it

7 years ago
Financing

Har­vard prof Omid Farokhzad heads west, set­ting up a new Bay Area biotech on a mis­sion to start a rev­o­lu­tion in pre-symp­to­matic dis­ease de­tec­tion

7 years ago
Financing

Black Di­a­mond turns down an open stretch of R&D high­way, head­ed to a show­down with onco­genes

7 years ago
Financing

Sue Dil­lon, Karyn O'Neil steer fledg­ling Aro Bio­ther­a­peu­tics to $13M de­but — with J&J's bless­ing

7 years ago
Financing

Vivek Ra­maswamy ramps up biotech start­up #14 — this time work­ing on a gene ther­a­py for sick­le cell dis­ease and β-tha­lassemia

7 years ago
First page Previous page 60616263646566 Next page Last page
A service from the Financial Times